An IPS in Valle de Aburrá began clinical studies with a new vaccine against Covid-19. The new method of application of this biological is intranasal and requires two doses.
To the new known methods of vaccination against Covid-19 The intranasal process is added, which consists of the application by means of a spray in the nostrils.
Until now, this method is in the testing phases, to which the IPS Clinisaludas one of the research centers authorized for this phase in Colombia.
Patients who are part of this process are subjected to different initial tests, in order to determine whether or not they are suitable for the application. Those who are part of the process receive a first dose and, two weeks later, they are given the booster for a subsequent follow-up of several weeks.
You may also be interested in: In Antioquia they will test intranasal vaccine against covid
The research doctor assures that this vaccine will have a double effect on people, because apart from protecting against covid-19, it will have action on the viruses that generate influenza.
As part of the requirements to take part in the clinical trials, patients must be over 18 years of age, six months after receiving the first or second dose against covid-19 or not having received any and not having had the disease. Recently.
Intranasal vaccine tests begin in the Valle de Aburrá
–
